Abstract
The recent increase in the incidence of tuberculosis with the emergence of multi-drug resistant (MDR) cases has lead to the search for new drugs that are effective against MDR strains of Mycobacterium tuberculosis (M. tb) and can augment the potential of existing drugs against tuberculosis. In the present study a series of naphthalene-1,4-dione derivatives were synthesized and evaluated for their in vitro antimycobacterial activity against M. tb H37Rv strain. Preliminary results indicated that most of the compounds demonstrated significant antimycobacterial activities. The most effective compounds of the series 7, 8 and 10 have MIC values of 3.13 μg/mL and growth inhibition of 99 %. Compound 7 has an IC50 value of 0.49 μg/mL. Compounds 1, 3 and 18 with MIC values of 3.13 μg/mL also showed 96-98 % growth inhibition. The objective of our study is to generate new leads through different mode of action and to optimize their structure to display the potent efficacy.
Keywords: Tuberculosis, antimycobacterial activity, naphthalene-1, 4-dione derivatives
Medicinal Chemistry
Title: Synthesis and Biological Evaluation of Naphthalene-1,4-dione Derivatives as Potent Antimycobacterial Agents
Volume: 4 Issue: 5
Author(s): A. Mital, V. S. Negi and U. Ramachandran
Affiliation:
Keywords: Tuberculosis, antimycobacterial activity, naphthalene-1, 4-dione derivatives
Abstract: The recent increase in the incidence of tuberculosis with the emergence of multi-drug resistant (MDR) cases has lead to the search for new drugs that are effective against MDR strains of Mycobacterium tuberculosis (M. tb) and can augment the potential of existing drugs against tuberculosis. In the present study a series of naphthalene-1,4-dione derivatives were synthesized and evaluated for their in vitro antimycobacterial activity against M. tb H37Rv strain. Preliminary results indicated that most of the compounds demonstrated significant antimycobacterial activities. The most effective compounds of the series 7, 8 and 10 have MIC values of 3.13 μg/mL and growth inhibition of 99 %. Compound 7 has an IC50 value of 0.49 μg/mL. Compounds 1, 3 and 18 with MIC values of 3.13 μg/mL also showed 96-98 % growth inhibition. The objective of our study is to generate new leads through different mode of action and to optimize their structure to display the potent efficacy.
Export Options
About this article
Cite this article as:
Mital A., Negi S. V. and Ramachandran U., Synthesis and Biological Evaluation of Naphthalene-1,4-dione Derivatives as Potent Antimycobacterial Agents, Medicinal Chemistry 2008; 4 (5) . https://dx.doi.org/10.2174/157340608785700243
DOI https://dx.doi.org/10.2174/157340608785700243 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vitamin D and Infectious Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Aptamers: Molecular Tools for Medical Diagnosis
Current Topics in Medicinal Chemistry Antibacterial Activity of Cissus incisa Extracts against Multidrug- Resistant Bacteria
Current Topics in Medicinal Chemistry Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Heat Shock Proteins And Neuroprotection
Recent Patents on DNA & Gene Sequences CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 Polymorphisms in Two Bantu-Speaking Populations from Cameroon and South Africa: Implications for Global Pharmacogenetics
Current Pharmacogenomics and Personalized Medicine Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology <i>Dichrostachys cinerea</i>: Ethnomedicinal Uses, Phytochemistry and Pharmacological Activities - A Review
The Natural Products Journal Polysaccharides to Combat Viruses (COVID-19) and Microbes: New updates
Current Molecular Pharmacology Non-Covalent Proteasome Inhibitors
Current Pharmaceutical Design Biological Properties of Yeast-based Mannoprotein for Prospective Biomedical Applications
Combinatorial Chemistry & High Throughput Screening Dietary Nitrite in Nitric Oxide Biology: A Redox Interplay with Implications for Pathophysiology and Therapeutics
Current Drug Targets Recent Advances in Nanosystems and Strategies for Managing Leishmaniasis
Current Drug Targets Cytokines in Systemic Lupus Erythematosus
Current Molecular Medicine HLA-E and HLA-E-Bound Peptides: Recognition by Subsets of NK and T Cells
Current Pharmaceutical Design Natural Product-Derived Small Molecule Activators of Hypoxia-Inducible Factor-1 (HIF-1)
Current Pharmaceutical Design Synthesis of Novel Amides Based on Acridone Scaffold with Interesting Antineoplastic Activity
Anti-Cancer Agents in Medicinal Chemistry Gauging Reactive Metabolites in Drug-Induced Toxicity
Current Medicinal Chemistry Gold Nanoparticle-Mediated High-Performance Enzyme-Linked Immunosorbent Assay for Detection of Tuberculosis ESAT-6 Protein
Micro and Nanosystems Lectin Techniques for Glycoproteomics
Current Proteomics